Valiant Laboratories IPO Lists at 15.8% Premium

Valiant Laboratories IPO Lists at 15.8% Premium
Valiant Laboratories IPO Lists at 15.8% Premium
Valiant Laboratories IPO Lists at 15.8% Premium
Valiant Laboratories IPO Lists at 15.8% Premium

Valiant Laboratories IPO Lists at 15.8% Premium

Valiant Laboratories IPO Lists at 15.8% Premium

Valiant Laboratories IPO Lists at 15.8% Premium

Valiant Laboratories, following a successful initial public offering (IPO), made its stock market debut with a strong premium. The listing price for Valiant Laboratories shares on the NSE was ₹162.15 per share, reflecting a 15.8% increase from the IPO issue price of ₹140. On the BSE, Valiant Laboratories shares were listed at ₹161 per share.

The Valiant Laboratories IPO was open for subscription from September 27 to October 3, offering shares at a price band of ₹133 to ₹140 per equity share. The allocation for the IPO was structured with up to 50% reserved for Qualified Institutional Buyers (QIBs), a minimum of 15% for Non-Institutional Investors (NIIs), and not less than 35% for Retail Investors.

The IPO, valued at ₹152.46 crores, consisted entirely of a fresh issue of 10,890,000 equity shares, with no offer for sale (OFS) component. The net proceeds from the offering will be allocated to various objectives, including investments in Valiant Advanced Sciences Private Limited (VASPL) and funding the working capital requirements of VASPL.

Unistone Capital Private Ltd served as the book-running lead manager for the Valiant IPO, and Link Intime India Private Ltd acted as the IPO registrar.

The grey market premium (GMP) for Valiant IPO today stood at +20, indicating that the shares were trading at a premium of ₹20 in the grey market. Considering the upper end of the IPO price band and the current GMP, the estimated listing price for Valiant Laboratories shares was ₹160 apiece, reflecting a 14.29% increase over the IPO issue price of ₹140.

The strong premium and positive market debut signal investors’ confidence in Valiant Laboratories, emphasizing the company’s growth potential in the specialty chemicals sector.

Facebook
Twitter
LinkedIn
Telegram
WhatsApp
Email
Note: You have to fill-up above all respective field, then click below button for send your message